Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes

[1]  Z. Chen,et al.  Host immunological response and factors associated with clinical outcome in patients with the novel influenza A H7N9 infection. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  R. Gao,et al.  Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections , 2014, Nature Communications.

[3]  Shigui Yang,et al.  Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients , 2014, Nature Communications.

[4]  P. Doherty,et al.  Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection , 2013, Proceedings of the National Academy of Sciences.

[5]  Zheng Xing,et al.  Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. , 2013, The Journal of infectious diseases.

[6]  G. Gao,et al.  Special Topic: Haunted with and Hunting for Viruses Haunted with and Hunting for Viruses , 2022 .

[7]  G. Gao,et al.  Lessons learnt from the human infections of avian-origin influenza A H7N9 virus: Live free markets and human health , 2013, Science China Life Sciences.

[8]  P. Lemey,et al.  Genesis of avian-origin H7N9 influenza A viruses , 2013, The Lancet.

[9]  Jie Dong,et al.  Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. , 2018 .

[10]  Ying Wu,et al.  Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human , 2013, Science China Life Sciences.

[11]  C. Kirkpatrick,et al.  Vascular Endothelial Cadherin Expression in Lung Specimens of Patients with Sepsis-Induced Acute Respiratory Distress Syndrome and Endothelial Cell Cultures , 2013, Pathobiology.

[12]  Wenjun Song,et al.  Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome , 2013, The Lancet.

[13]  B. Cao,et al.  Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury , 2013, Cell Research.

[14]  Tian Bai,et al.  Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China , 2013 .

[15]  B. Cao,et al.  IL-17 response mediates acute lung injury induced by the 2009 Pandemic Influenza A (H1N1) Virus , 2011, Cell Research.

[16]  R. Bellomo,et al.  Why we should be wary of single-center trials , 2009, Critical care medicine.

[17]  P. Fietta,et al.  The effector T helper cell triade. , 2009, Rivista di biologia.

[18]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[19]  J. Sung,et al.  Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome , 2005, Clinical chemistry.

[20]  P. Wernet,et al.  Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. , 2005, Experimental hematology.

[21]  Jun Xu,et al.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. , 2005, American journal of respiratory and critical care medicine.

[22]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[23]  B. Damaj,et al.  Expression and regulation of chemokine receptors in human natural killer cells. , 2001, Blood.

[24]  R. Kastelein,et al.  IL‐10 enhances NK cell proliferation, cytotoxicity and production of IFN‐γ when combined with IL‐18 , 1999, European journal of immunology.

[25]  J. Nikliński,et al.  Stem Cell Factor and Granulocyte-Macrophage-Colony Stimulating Factor as Candidates for Tumour Markers for Non-Small-Cell Lung Cancer , 1999, Clinical chemistry and laboratory medicine.

[26]  J. Taipale,et al.  Hepatocyte Growth Factor Releases Epithelial and Endothelial Cells from Growth Arrest Induced by Transforming Growth Factor-1 (*) , 1996, The Journal of Biological Chemistry.

[27]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.